Wang SV - Search Results

1

Extension of Disease Risk Score-Based Confounding Adjustments for Multiple Outcomes of Interest: An Empirical Evaluation.

Desai RJ, Wyss R, Jin Y, Bohn J, Toh S, Cosgrove A, Kennedy A, Kim J, Kim C, Ouellet-Hellstrom R, Karami S, Major JM, Niman A, Wang SV, Gagne JJ. Desai RJ, et al. Among authors: wang sv. Am J Epidemiol. 2018 Nov 1;187(11):2439-2448. doi: 10.1093/aje/kwy130. Am J Epidemiol. 2018. PMID: 29947726

2

Case-crossover studies of therapeutics: design approaches to addressing time-varying prognosis in elderly populations.

Wang SV, Gagne JJ, Glynn RJ, Schneeweiss S. Wang SV, et al. Epidemiology. 2013 May;24(3):375-8. doi: 10.1097/EDE.0b013e31828ac9cb. Epidemiology. 2013. PMID: 23466528 Free PMC article.

3

Estimation using all available covariate information versus a fixed look-back window for dichotomous covariates.

Brunelli SM, Gagne JJ, Huybrechts KF, Wang SV, Patrick AR, Rothman KJ, Seeger JD. Brunelli SM, et al. Among authors: wang sv. Pharmacoepidemiol Drug Saf. 2013 May;22(5):542-50. doi: 10.1002/pds.3434. Epub 2013 Mar 22. Pharmacoepidemiol Drug Saf. 2013. PMID: 23526818 Free PMC article.

4

A modular, prospective, semi-automated drug safety monitoring system for use in a distributed data environment.

Gagne JJ, Wang SV, Rassen JA, Schneeweiss S. Gagne JJ, et al. Among authors: wang sv. Pharmacoepidemiol Drug Saf. 2014 Jun;23(6):619-27. doi: 10.1002/pds.3616. Epub 2014 Apr 30. Pharmacoepidemiol Drug Saf. 2014. PMID: 24788694 Free PMC article.

5

Optimal matching ratios in drug safety surveillance.

Wang SV, Schneeweiss S, Rassen JA. Wang SV, et al. Epidemiology. 2014 Sep;25(5):772-3. doi: 10.1097/EDE.0000000000000148. Epidemiology. 2014. PMID: 25076153 No abstract available.

6

"First-wave" bias when conducting active safety monitoring of newly marketed medications with outcome-indexed self-controlled designs.

Wang SV, Schneeweiss S, Maclure M, Gagne JJ. Wang SV, et al. Am J Epidemiol. 2014 Sep 15;180(6):636-44. doi: 10.1093/aje/kwu162. Epub 2014 Aug 1. Am J Epidemiol. 2014. PMID: 25086050 Free PMC article.

7

Pharmacoepidemiological assessment of drug interactions with vitamin K antagonists.

Pottegård A, dePont Christensen R, Wang SV, Gagne JJ, Larsen TB, Hallas J. Pottegård A, et al. Among authors: wang sv. Pharmacoepidemiol Drug Saf. 2014 Nov;23(11):1160-7. doi: 10.1002/pds.3714. Epub 2014 Sep 24. Pharmacoepidemiol Drug Saf. 2014. PMID: 25250949

8

Prediction of rates of thromboembolic and major bleeding outcomes with dabigatran or warfarin among patients with atrial fibrillation: new initiator cohort study.

Wang SV, Franklin JM, Glynn RJ, Schneeweiss S, Eddings W, Gagne JJ. Wang SV, et al. BMJ. 2016 May 24;353:i2607. doi: 10.1136/bmj.i2607. BMJ. 2016. PMID: 27221664 Free PMC article.

9

Use of electronic healthcare records to identify complex patients with atrial fibrillation for targeted intervention.

Wang SV, Rogers JR, Jin Y, Bates DW, Fischer MA. Wang SV, et al. J Am Med Inform Assoc. 2017 Mar 1;24(2):339-344. doi: 10.1093/jamia/ocw082. J Am Med Inform Assoc. 2017. PMID: 27375290 Free PMC article.

10

Successful Comparison of US Food and Drug Administration Sentinel Analysis Tools to Traditional Approaches in Quantifying a Known Drug-Adverse Event Association.

Gagne JJ, Han X, Hennessy S, Leonard CE, Chrischilles EA, Carnahan RM, Wang SV, Fuller C, Iyer A, Katcoff H, Woodworth TS, Archdeacon P, Meyer TE, Schneeweiss S, Toh S. Gagne JJ, et al. Among authors: wang sv. Clin Pharmacol Ther. 2016 Nov;100(5):558-564. doi: 10.1002/cpt.429. Epub 2016 Aug 22. Clin Pharmacol Ther. 2016. PMID: 27416001 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

114 results

Search Page

Filters